42 research outputs found

    Greenland Ice Sheet Surface Melt and Its Relation to Daily Atmospheric Conditions

    Get PDF
    Melt area is one of the most reliably monitored variables associated with surface conditions over the full Greenland Ice Sheet (GrIS). Surface melt is also an important indicator of surface mass balance and has potential relevance to the ice sheet's global sea level contribution. Melt events are known to be spatially heterogeneous and have varying time scales. To understand the forcing mechanisms, it is necessary to examine the relation between the existing conditions and melt area on the time scales that melt is observed. Here, we conduct a regression analysis of atmospheric reanalysis variables including sea level pressure, near-surface winds, and components of the surface energy budget with surface melt. The regression analysis finds spatial heterogeneity in the associated atmospheric circulation conditions. For basins in the southern GrIS, there is an association between melt area and high pressure located south of the Denmark Strait, which allows for southerly flow over the western half of the GrIS. Instantaneous surface melt over northern basins is also associated with low pressure over the central Arctic. Basins associated with persistent summer melt in the southern and western GrIS are associated with the presence of an enhanced cloud cover, a resulting decreased downwelling solar radiative flux, and an enhanced downwelling longwave radiative flux. This contrasts with basins to the north and east, where an increased downwelling solar radiative flux plays a more important role in the onset of a melt event. The analysis emphasizes the importance of daily variability in synoptic conditions and their preferred association with melt events

    Evaluation of the Surface Representation of the Greenland Ice Sheet in a General Circulation Model

    Get PDF
    Simulated surface conditions of the Goddard Earth Observing System model, version 5 (GEOS 5) atmospheric general circulation model (AGCM) are examined for the contemporary Greenland Ice Sheet (GrIS). A surface parameterization that explicitly models surface processes including snow compaction, meltwater percolation and refreezing, and surface albedo is found to remedy an erroneous deficit in the annual net surface energy flux and provide an adequate representation of surface mass balance (SMB) in an evaluation using simulations at two spatial resolutions. The simulated 1980-2008 GrIS SMB average is 24.7+/-4.5 cm yr(- 1) water-equivalent (w.e.) at.5 degree model grid spacing, and 18.2+/-3.3 cm yr(- 1) w.e. for 2 degree grid spacing. The spatial variability and seasonal cycle of the simulation compare favorably to recent studies using regional climate models, while results from 2 degree integrations reproduce the primary features of the SMB field. In comparison to historical glaciological observations, the coarser resolution model overestimates accumulation in the southern areas of the GrIS, while the overall SMB is underestimated. These changes relate to the sensitivity of accumulation and melt to the resolution of topography. The GEOS-5 SMB fields contrast with available corresponding atmospheric models simulations from the Coupled Model Intercomparison Project (CMIP5). It is found that only a few of the CMIP5 AGCMs examined provide significant summertime runoff, a dominant feature of the GrIS seasonal cycle. This is a condition that will need to be remedied if potential contributions to future eustatic change from polar ice sheets are to be examined with GCMs

    Experimental protocol for sea level projections from ISMIP6 stand-alone ice sheet models

    Get PDF
    Projection of the contribution of ice sheets to sea level change as part of the Coupled Model Intercomparison Project Phase 6 (CMIP6) takes the form of simulations from coupled ice sheet–climate models and stand-alone ice sheet models, overseen by the Ice Sheet Model Intercomparison Project for CMIP6 (ISMIP6). This paper describes the experimental setup for process-based sea level change projections to be performed with stand-alone Greenland and Antarctic ice sheet models in the context of ISMIP6. The ISMIP6 protocol relies on a suite of polar atmospheric and oceanic CMIP-based forcing for ice sheet models, in order to explore the uncertainty in projected sea level change due to future emissions scenarios, CMIP models, ice sheet models, and parameterizations for ice–ocean interactions. We describe here the approach taken for defining the suite of ISMIP6 stand-alone ice sheet simulations, document the experimental framework and implementation, and present an overview of the ISMIP6 forcing to be used by participating ice sheet modeling groups

    Facial expression training optimises viewing strategy in children and adults

    Get PDF
    This study investigated whether training-related improvements in facial expression categorization are facilitated by spontaneous changes in gaze behaviour in adults and nine-year old children. Four sessions of a self-paced, free-viewing training task required participants to categorize happy, sad and fear expressions with varying intensities. No instructions about eye movements were given. Eye-movements were recorded in the first and fourth training session. New faces were introduced in session four to establish transfer-effects of learning. Adults focused most on the eyes in all sessions and increased expression categorization accuracy after training coincided with a strengthening of this eye-bias in gaze allocation. In children, training-related behavioural improvements coincided with an overall shift in gaze-focus towards the eyes (resulting in more adult-like gaze-distributions) and towards the mouth for happy faces in the second fixation. Gaze-distributions were not influenced by the expression intensity or by the introduction of new faces. It was proposed that training enhanced the use of a uniform, predominantly eyes-biased, gaze strategy in children in order to optimise extraction of relevant cues for discrimination between subtle facial expressions

    Large expert-curated database for benchmarking document similarity detection in biomedical literature search

    Get PDF
    Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe

    Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

    Get PDF
    BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years
    corecore